ABOUT PSI

), can help to explain why KIF15 is ready to aid resistance to Eg5 inhibitors in vivo. MT gliding run by equally of such mitotic motors was arrested only if they had been individually inhibited, lending support to your proposal that a mix drug therapy targeting these motors may be a workable tactic for conquering chemotherapeutic resistance to Eg5